Patent details

Basic Information

Publication number:

EP2872653

PCT Application Number:

US2013050362

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP138171145

PCT Publication Number:

WO2014012051

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PERSONALIZED CANCER VACCINES AND ADOPTIVE IMMUNE CELL THERAPIES

French Title of Invention:

VACCINS ANTICANCÉREUX PERSONNALISÉS ET THÉRAPIES CELLULAIRES IMMUNITAIRES ADOPTIVES

German Title of Invention:

PERSONALISIERTE KREBSIMPFSTOFFE UND ADAPTIVE IMMUNZELLTHERAPIEN

SPC Number:

Dates

Filing date:

12/07/2013

Grant date:

13/03/2019

EP Publication Date:

20/05/2015

PCT Publication Date:

16/01/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/03/2019

EP B1 Publication Date:

13/03/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/07/2019

Expiration date:

12/07/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/03/2019

 

 

Name:

Persimmune, Inc.

Address:

11555 Sorrento Valley Road, San Diego, CA 92121, United States (US)

Inventor

Name:

VITIELLO, Maria, Antonia

Address:

United States (US)

Priority

Priority Number:

201261670931 P

Priority Date:

12/07/2012

Priority Country:

United States (US)

Classification

IPC classification:

G06F 19/18; A61K 39/00; A61K 35/17; C12Q 1/6874; C12Q 1/6881; C12Q 1/6888;

Publication

European Patent Bulletin

Issue number:

201911

Publication date:

13/03/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages